Sign up
Pharma Capital

Hemispherx Biopharma appoints Ellen Lintal as chief accountant

Hemispherx Biopharma Inc (NYSEAMERICAN:HEB) CEO Tom Equels tells Proactive Investors the biotech company has promoted Ellen Lintal as its new chief accounting officer, from vice-president of finance and control.

Equels says Lintal has experience with M&A, which Equels says, will advance the company's business plan.


View full HEB profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.